{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:50:47Z","timestamp":1794379847100,"version":"4.9.0"},"reference-count":38,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"12","funder":[{"DOI":"10.13039\/501100000297","name":"Royal College of Surgeons of England","doi-asserted-by":"publisher","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/501100000297","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kennedy Institute of Rheumatology","award":["MSP 13 14 11"],"award-info":[{"award-number":["MSP 13 14 11"]}]},{"name":"Oxford Celgene fellowship","award":["AZR00610"],"award-info":[{"award-number":["AZR00610"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Adv."],"published-print":{"date-parts":[[2019,12,6]]},"abstract":"<jats:p>IL-33 mediates cross-talk between immune and stromal cells in localized fibrosis.<\/jats:p>","DOI":"10.1126\/sciadv.aay0370","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:22:51Z","timestamp":1575505371000},"source":"Crossref","is-referenced-by-count":38,"title":["Identification of TNFR2 and IL-33 as therapeutic targets in localized fibrosis"],"prefix":"10.1126","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6963-2255","authenticated-orcid":true,"given":"David","family":"Izadi","sequence":"first","affiliation":[{"name":"The Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1934-7234","authenticated-orcid":true,"given":"Thomas B.","family":"Layton","sequence":"additional","affiliation":[{"name":"The Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Williams","sequence":"additional","affiliation":[{"name":"The Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8151-8781","authenticated-orcid":true,"given":"Fiona","family":"McCann","sequence":"additional","affiliation":[{"name":"The Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8542-8967","authenticated-orcid":true,"given":"Marisa","family":"Cabrita","sequence":"additional","affiliation":[{"name":"The Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Espirito Santo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilin","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Inflammation Research, Celgene Corporation, San Diego, CA, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8712-7471","authenticated-orcid":true,"given":"Marco","family":"Fritzsche","sequence":"additional","affiliation":[{"name":"The Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6585-3237","authenticated-orcid":true,"given":"Huw","family":"Colin-York","sequence":"additional","affiliation":[{"name":"The Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Feldmann","sequence":"additional","affiliation":[{"name":"The Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8813-2977","authenticated-orcid":true,"given":"Kim S.","family":"Midwood","sequence":"additional","affiliation":[{"name":"The Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9579-9411","authenticated-orcid":true,"given":"Jagdeep","family":"Nanchahal","sequence":"additional","affiliation":[{"name":"The Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2807"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1607896113"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.prs.0000438455.37604.0f","article-title":"A systematic review and meta-analysis on the prevalence of dupuytren disease in the general population of western countries","volume":"133","author":"Lanting R.","year":"2014","unstructured":"R. Lanting, D. C. Broekstra, P. M. N. Werker, E. R. van den Heuvel, A systematic review and meta-analysis on the prevalence of dupuytren disease in the general population of western countries. Plast. Reconstr. Surg. 133, 593\u2013603 (2014).","journal-title":"Plast. Reconstr. Surg."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jhsa.2005.03.005","article-title":"A retrospective review of the management of Dupuytren\u2019s nodules","volume":"30","author":"Reilly R. M.","year":"2005","unstructured":"R. M. Reilly, P. J. Stern, C. A. Goldfarb, A retrospective review of the management of Dupuytren\u2019s nodules. J. Hand Surg. Am. 30, 1014\u20131018 (2005).","journal-title":"J. Hand Surg. Am."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jhsa.2013.03.036","article-title":"The impact of Dupuytren disease on patient activity and quality of life","volume":"38","author":"Wilburn J.","year":"2013","unstructured":"J. Wilburn, S. P. McKenna, D. Perry-Hinsley, A. Bayat, The impact of Dupuytren disease on patient activity and quality of life. J. Hand Surg. Am. 38, 1209\u20131214 (2013).","journal-title":"J. Hand Surg. Am."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032712-095937"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"E928","DOI":"10.1073\/pnas.1301100110","article-title":"Unraveling the signaling pathways promoting fibrosis in Dupuytren\u2019s disease reveals TNF as a therapeutic target","volume":"110","author":"Verjee L. S.","year":"2013","unstructured":"L. S. Verjee, J. S. N. Verhoekx, J. K. K. Chan, T. Krausgruber, V. Nicolaidou, D. Izadi, D. Davidson, M. Feldmann, K. S. Midwood, J. Nanchahal, Unraveling the signaling pathways promoting fibrosis in Dupuytren\u2019s disease reveals TNF as a therapeutic target. Proc. Natl. Acad. Sci. U.S.A. 110, E928\u2013E937 (2013).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ebiom.2018.06.022","article-title":"Anti-tumour necrosis factor therapy for Dupuytren\u2019s disease: A randomised dose response proof of concept phase 2a clinical trial","volume":"33","author":"Nanchahal J.","year":"2018","unstructured":"J. Nanchahal, C. Ball, D. Davidson, L. Williams, W. Sones, F. E. McCann, M. Cabrita, J. Swettenham, N. J. Cahoon, B. Copsey, E. Anne Francis, P. C. Taylor, J. Black, V. S. Barber, S. Dutton, M. Feldmann, S. E. Lamb, Anti-tumour necrosis factor therapy for Dupuytren\u2019s disease: A randomised dose response proof of concept phase 2a clinical trial. EBioMedicine 33, 282\u2013288 (2018).","journal-title":"EBioMedicine"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.12688\/wellcomeopenres.11466.1","article-title":"Study protocol: A multi-centre, double blind, randomised, placebo-controlled, parallel group, phase II trial (RIDD) to determine the efficacy of intra-nodular injection of anti-TNF to control disease progression in early Dupuytren's disease, with an embedded dose response study","volume":"2","author":"Nanchahal J.","year":"2017","unstructured":"J. Nanchahal, C. Ball, J. Swettenham, S. Dutton, V. Barber, J. Black, B. Copsey, M. Dritsaki, P. Taylor, A. Gray, M. Feldmann, S. Lamb, Study protocol: A multi-centre, double blind, randomised, placebo-controlled, parallel group, phase II trial (RIDD) to determine the efficacy of intra-nodular injection of anti-TNF to control disease progression in early Dupuytren's disease, with an embedded dose response study. Wellcome Open Res. 2, 37 (2017).","journal-title":"Wellcome Open Res."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.04.019"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00478"},{"key":"e_1_3_2_13_2","first-page":"F766","article-title":"Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy","volume":"277","author":"Guo G.","year":"1999","unstructured":"G. Guo, J. Morrissey, R. McCracken, T. Tolley, S. Klahr, Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Am. J. Physiol. 277, F766\u2013F772 (1999).","journal-title":"Am. J. Physiol."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"36099","DOI":"10.1074\/jbc.M505291200","article-title":"Tumor necrosis factor (TNF) \u03b1 increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2","volume":"280","author":"Theiss A. L.","year":"2005","unstructured":"A. L. Theiss, J. G. Simmons, C. Jobin, P. K. Lund, Tumor necrosis factor (TNF) \u03b1 increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2. J. Biol. Chem. 280, 36099\u201336109 (2005).","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nrrheum.2010.180","article-title":"Scientific understanding and clinical management of Dupuytren disease","volume":"6","author":"Shih B.","year":"2010","unstructured":"B. Shih, A. Bayat, Scientific understanding and clinical management of Dupuytren disease. Nat. Rev. Rheumatol. 6, 715\u2013726 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI62423"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.95"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.07.018"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jhsa.2009.08.005","article-title":"Myofibroblast distribution in Dupuytren\u2019s cords: Correlation with digital contracture","volume":"34","author":"Verjee L. S.","year":"2009","unstructured":"L. S. Verjee, K. Midwood, D. Davidson, D. Essex, A. Sandison, J. Nanchahal, Myofibroblast distribution in Dupuytren\u2019s cords: Correlation with digital contracture. J. Hand Surg. Am. 34, 1785\u20131794 (2009).","journal-title":"J. Hand Surg. Am."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.12703\/P6-13"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.06.008"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000087640","article-title":"Chemokine receptor expression by mast cells","volume":"87","author":"Juremalm M.","year":"2005","unstructured":"M. Juremalm, G. Nilsson, Chemokine receptor expression by mast cells. Chem. Immunol. Allergy 87, 130\u2013144 (2005).","journal-title":"Chem. Immunol. Allergy"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120145"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.05.011"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903306"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901575"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature13577"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.10.7303"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.298703"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0912678107"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"h2809","DOI":"10.1136\/bmj.h2809","article-title":"Association between tumour necrosis factor-\u03b1 inhibitors and risk of serious infections in people with inflammatory bowel disease: Nationwide Danish cohort study","volume":"350","author":"Nyboe Andersen N.","year":"2015","unstructured":"N. Nyboe Andersen, B. Pasternak, N. Friis-M\u00f8ller, M. Andersson, T. Jess, Association between tumour necrosis factor-\u03b1 inhibitors and risk of serious infections in people with inflammatory bowel disease: Nationwide Danish cohort study. BMJ 350, h2809 (2015).","journal-title":"BMJ"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00300.2014"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2010.120"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrgastro.2012.256","article-title":"Liver fibrosis in 2012: Convergent pathways that cause hepatic fibrosis in NASH","volume":"10","author":"Friedman S. L.","year":"2013","unstructured":"S. L. Friedman, Liver fibrosis in 2012: Convergent pathways that cause hepatic fibrosis in NASH. Nat. Rev. Gastroenterol. Hepatol. 10, 71\u201372 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200522675"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.02.015"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2014.7"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrrheum.2017.115","article-title":"Synovial tissue research: A state-of-the-art review","volume":"13","author":"Orr C.","year":"2017","unstructured":"C. Orr, E. Vieira-Sousa, D. L. Boyle, M. H. Buch, C. D. Buckley, J. D. Ca\u00f1ete, A. I. Catrina, E. H. S. Choy, P. Emery, U. Fearon, A. Filer, D. Gerlag, F. Humby, J. D. Isaacs, S. A. Just, B. R. Lauwerys, B. le Goff, A. Manzo, T. McGarry, I. B. McInnes, A. Najm, C. Pitzalis, A. Pratt, M. Smith, P. P. Tak, S. W. Tas, R. Thurlings, J. E. Fonseca, D. J. Veale, Synovial tissue research: A state-of-the-art review. Nat. Rev. Rheumatol. 13, 463\u2013475 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/bs.mcb.2014.10.008","article-title":"Measurement of cell traction forces with ImageJ","volume":"125","author":"Martiel J.-L.","year":"2015","unstructured":"J.-L. Martiel, A. Leal, L. Kurzawa, M. Balland, I. Wang, T. Vignaud, Q. Tseng, M. Th\u00e9ry, Measurement of cell traction forces with ImageJ. Methods Cell Biol. 125, 269\u2013287 (2015).","journal-title":"Methods Cell Biol."}],"container-title":["Science Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/sciadv.aay0370","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T19:56:43Z","timestamp":1704830203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/sciadv.aay0370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,6]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12,6]]}},"alternative-id":["10.1126\/sciadv.aay0370"],"URL":"https:\/\/doi.org\/10.1126\/sciadv.aay0370","relation":{},"ISSN":["2375-2548"],"issn-type":[{"value":"2375-2548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,6]]},"article-number":"eaay0370"}}